These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9300794)

  • 1. Characterization of hydrogen peroxide removal activities in mouse hemolysates: catalase activity and hydrogen peroxide removal activity by hemoglobin.
    Masuoka N; Wakimoto M; Ohta J; Ishii K; Nakano T
    Biochim Biophys Acta; 1997 Aug; 1361(2):131-7. PubMed ID: 9300794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of hydrogen peroxide removal reaction by hemoglobin in the presence of reduced pyridine nucleotides.
    Masuoka N; Kodama H; Abe T; Wang DH; Nakano T
    Biochim Biophys Acta; 2003 Jan; 1637(1):46-54. PubMed ID: 12527406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of alpha-tocopherol on methemoglobin formation by nitric oxide in normal and acatalasemic mouse hemolysates.
    Zhen LX; Ishii K; Taketa K; Ogata M
    Physiol Chem Phys Med NMR; 1993; 25(4):253-60. PubMed ID: 8153151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrophotometric determination of hydrogen peroxide: catalase activity and rates of hydrogen peroxide removal by erythrocytes.
    Masuoka N; Wakimoto M; Ubuka T; Nakano T
    Clin Chim Acta; 1996 Oct; 254(2):101-12. PubMed ID: 8896899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methemoglobin formation in the blood of Japanese subjects and mice suffering from acatalasemia in response to methemoglobin inducers.
    Ogata M; Ishii K; Ioku N; Meguro T
    Physiol Chem Phys Med NMR; 1990; 22(3):125-34. PubMed ID: 2093192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of acatalasemic erythrocytes treated with low and high dose hydrogen peroxide. Hemolysis and aggregation.
    Masuoka N; Sugiyama H; Ishibashi N; Wang DH; Masuoka T; Kodama H; Nakano T
    J Biol Chem; 2006 Aug; 281(31):21728-21734. PubMed ID: 16751193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro mercury uptake by human acatalasemic erythrocytes.
    Ogata M; Ikeda M
    Arch Environ Health; 1979; 34(4):218-21. PubMed ID: 475461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methemoglobin formation by potassium ferrocyanide in the hemolysate of acatalasemic mice.
    Ohmori T; Ogata M
    Acta Med Okayama; 1991 Aug; 45(4):209-15. PubMed ID: 1962528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of liver catalase in acatalasemic beagle dog: comparison with normal dog liver catalase.
    Nakamura K; Watanabe M; Sasaki Y; Ikeda T
    Int J Biochem Cell Biol; 2000 Jan; 32(1):89-98. PubMed ID: 10661897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a protease inhibitor on the stability of catalase in liver and blood from acatalasemic and normal mice.
    Suzuki K; Ogata M
    Acta Med Okayama; 1991 Oct; 45(5):363-9. PubMed ID: 1755340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of glutathione peroxidase activity and its contribution to hydrogen peroxide removal in erythrocytes.
    Wakimoto M; Masuoka N; Nakano T; Ubuka T
    Acta Med Okayama; 1998 Oct; 52(5):233-7. PubMed ID: 9810432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoelectric focusing of catalase from acatalasemic mouse and human blood, and cultured human skin fibroblasts.
    Ogata M; Satoh Y
    Electrophoresis; 1988 Mar; 9(3):128-31. PubMed ID: 3234345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotitration of the catalase in the blood of Japanese subjects and mice suffering from acatalasemia and hypocatalasemia.
    Ogata M; Fujii Y
    Physiol Chem Phys Med NMR; 1992; 24(4):261-9. PubMed ID: 1296208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte defense against hydrogen peroxide: preeminent importance of catalase.
    Scott MD; Lubin BH; Zuo L; Kuypers FA
    J Lab Clin Med; 1991 Jul; 118(1):7-16. PubMed ID: 2066646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and cellular characteristics of a hepatocyte cell line (OUMS-31) derived from an acatalasemic mouse.
    Kondo A; Miyazaki M; Pu H; Gao C; Namba M
    In Vitro Cell Dev Biol Anim; 1999 Mar; 35(3):155-8. PubMed ID: 10476912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro mercury uptake by hypocatalasemic and acatalasemic mouse hemolysates and human acatalasemic hemolysates.
    Okata M; Kenmotsu K; Naito M; Meguro T; Hirota N
    Ind Health; 1980; 18(4):217-20. PubMed ID: 7251404
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory effects of prior low-dose X-ray irradiation on carbon tetrachloride-induced hepatopathy in acatalasemic mice.
    Yamaoka K; Kataoka T; Nomura T; Taguchi T; Wang DH; Mori S; Hanamoto K; Kira S
    J Radiat Res; 2004 Mar; 45(1):89-95. PubMed ID: 15133295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing variable oxidative hemolysis of inbred mouse erythrocytes.
    Kruckeberg WC
    Biochim Biophys Acta; 1991 Sep; 1094(3):288-91. PubMed ID: 1911880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired in vitro accumulation of mercury in erythrocytes of acatalasemic mice.
    Yamamoto H; Ishii K; Meguro T; Taketa K; Ogata M
    Acta Med Okayama; 1992 Apr; 46(2):67-73. PubMed ID: 1575060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of hydrogen peroxide promoted by homocysteine and inherited catalase deficiency on human hypocatalasemic patients.
    Góth L; Vitai M
    Free Radic Biol Med; 2003 Oct; 35(8):882-8. PubMed ID: 14556852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.